GLENMARK:NSE
Glenmark Pharmaceuticals Ltd
₹2,226.70
arrow_downward
-1.06%(-23.80) 1D
Oct 16, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLENMARK...
Open
₹2,250.50
High
₹2,266.90
Low
₹2,223.70
Mkt. cap
628.43B
Avg. vol.
539.28K
Volume
695.43K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
34.96
52-wk high
₹2,537.60
52-wk low
₹1,792.60
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
Open
₹2,250.50
High
₹2,266.90
Low
₹2,223.70
Mkt. cap
628.43B
Avg. vol.
539.28K
Volume
695.43K
Dividend
0.22%
Quarterly dividend
₹1.25
Ex-dividend date
Oct 3, 2025
P/E ratio
34.96
52-wk high
₹2,537.60
52-wk low
₹1,792.60
EPS
₹63.68
Shares outstanding
0.00
No. of employees
17K
News stories
From web sources and news partners
MarketWatch
·
27 minutes ago
Opinion: There is a silent market rotation inside the S&P 500 that’s warning of more weakness ahead
FinanceFeeds
·
1 hour ago
Equal-weight S&P 500 at $214.09, down 0.42%, 84% beat rate
FOREX.com
·
8 hours ago
S&P 500, Nasdaq, Dow and Russell 2000 For the Week Ahead
디지털투데이
·
13 hours ago
Bitcoin could fall to $10,000 if S&P 500 drops 20 percent - Bloomberg
Profile
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company based in Mumbai. Founded in 1977 by Gracias Saldanha as a generic drug and active pharmaceutical ingredient manufacturer, it is listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company produces and distributes medicines in more than 80 countries, with operations concentrated in India, North America, Europe, and emerging markets. As of March 2026, it employed approximately 17,000 people. Its name derives from Saldanha's sons, Glenn and Mark. Wikipedia
About Glenmark Pharmaceuticals Ltd